1 Oncology Therapeutic Drug Market Overview

• 1.1 Product Overview and Scope of Oncology Therapeutic Drug
• 1.2 Oncology Therapeutic Drug Segment by Type
• 1.2.1 Global Oncology Therapeutic Drug Sales Growth Rate Comparison by Type (2022-2028)

1.2.2 Chemotherapy

1.2.3 Targeted Therapy

1.2.4 Immunotherapy

1.2.5 Hormonal Therapy

1.2.6 Others

1.3 Oncology Therapeutic Drug Segment by Application

1.3.1 Global Oncology Therapeutic Drug Sales Comparison by Application: (2022-2028)

1.3.2 Breast Cancer

1.3.3 Gastrointestinal Cancer

1.3.4 Prostate Cancer

1.3.5 Respiratory and Lung Cancer

1.3.6 Others

1.4 Global Oncology Therapeutic Drug Market Size Estimates and Forecasts

1.4.1 Global Oncology Therapeutic Drug Revenue 2017-2028

1.4.2 Global Oncology Therapeutic Drug Sales 2017-2028

1.4.3 Oncology Therapeutic Drug Market Size by Region: 2017 Versus 2021 Versus 2028

2 Oncology Therapeutic Drug Market Competition by Manufacturers

• 2.1 Global Oncology Therapeutic Drug Sales Market Share by Manufacturers (2017-2022)
• 2.2 Global Oncology Therapeutic Drug Revenue Market Share by Manufacturers (2017-2022)
• 2.3 Global Oncology Therapeutic Drug Average Price by Manufacturers (2017-2022)
• 2.4 Manufacturers Oncology Therapeutic Drug Manufacturing Sites, Area Served, Product Type
• 2.5 Oncology Therapeutic Drug Market Competitive Situation and Trends
• 2.5.1 Oncology Therapeutic Drug Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Oncology Therapeutic Drug Players Market Share by Revenue

2.5.3 Global Oncology Therapeutic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Oncology Therapeutic Drug Retrospective Market Scenario by Region

• 3.1 Global Oncology Therapeutic Drug Retrospective Market Scenario in Sales by Region: 2017-2022
• 3.2 Global Oncology Therapeutic Drug Retrospective Market Scenario in Revenue by Region: 2017-2022
• 3.3 North America Oncology Therapeutic Drug Market Facts & Figures by Country
• 3.3.1 North America Oncology Therapeutic Drug Sales by Country

3.3.2 North America Oncology Therapeutic Drug Revenue by Country

3.3.3 United States

3.3.4 Canada

3.4 Europe Oncology Therapeutic Drug Market Facts & Figures by Country

3.4.1 Europe Oncology Therapeutic Drug Sales by Country

3.4.2 Europe Oncology Therapeutic Drug Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Oncology Therapeutic Drug Market Facts & Figures by Region

3.5.1 Asia Pacific Oncology Therapeutic Drug Sales by Region

3.5.2 Asia Pacific Oncology Therapeutic Drug Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 China Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.6 Latin America Oncology Therapeutic Drug Market Facts & Figures by Country

3.6.1 Latin America Oncology Therapeutic Drug Sales by Country

3.6.2 Latin America Oncology Therapeutic Drug Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.6.6 Colombia

3.7 Middle East and Africa Oncology Therapeutic Drug Market Facts & Figures by Country

3.7.1 Middle East and Africa Oncology Therapeutic Drug Sales by Country

3.7.2 Middle East and Africa Oncology Therapeutic Drug Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 UAE

4 Global Oncology Therapeutic Drug Historic Market Analysis by Type

• 4.1 Global Oncology Therapeutic Drug Sales Market Share by Type (2017-2022)
• 4.2 Global Oncology Therapeutic Drug Revenue Market Share by Type (2017-2022)
• 4.3 Global Oncology Therapeutic Drug Price by Type (2017-2022)

5 Global Oncology Therapeutic Drug Historic Market Analysis by Application

• 5.1 Global Oncology Therapeutic Drug Sales Market Share by Application (2017-2022)
• 5.2 Global Oncology Therapeutic Drug Revenue Market Share by Application (2017-2022)
• 5.3 Global Oncology Therapeutic Drug Price by Application (2017-2022)

6 Key Companies Profiled

• 6.1 AbbVie
• 6.1.1 AbbVie Corporation Information

6.1.2 AbbVie Description and Business Overview

6.1.3 AbbVie Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)

6.1.4 AbbVie Oncology Therapeutic Drug Product Portfolio

6.1.5 AbbVie Recent Developments/Updates

6.2 Amgen

6.2.1 Amgen Corporation Information

6.2.2 Amgen Description and Business Overview

6.2.3 Amgen Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)

6.2.4 Amgen Oncology Therapeutic Drug Product Portfolio

6.2.5 Amgen Recent Developments/Updates

6.3 Astellas Pharma

6.3.1 Astellas Pharma Corporation Information

6.3.2 Astellas Pharma Description and Business Overview

6.3.3 Astellas Pharma Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)

6.3.4 Astellas Pharma Oncology Therapeutic Drug Product Portfolio

6.3.5 Astellas Pharma Recent Developments/Updates

6.4 AstraZeneca

6.4.1 AstraZeneca Corporation Information

6.4.2 AstraZeneca Description and Business Overview

6.4.3 AstraZeneca Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)

6.4.4 AstraZeneca Oncology Therapeutic Drug Product Portfolio

6.4.5 AstraZeneca Recent Developments/Updates

6.5 Bayer

6.5.1 Bayer Corporation Information

6.5.2 Bayer Description and Business Overview

6.5.3 Bayer Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)

6.5.4 Bayer Oncology Therapeutic Drug Product Portfolio

6.5.5 Bayer Recent Developments/Updates

6.6 Biogen

6.6.1 Biogen Corporation Information

6.6.2 Biogen Description and Business Overview

6.6.3 Biogen Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)

6.6.4 Biogen Oncology Therapeutic Drug Product Portfolio

6.6.5 Biogen Recent Developments/Updates

6.7 Bristol Myers Squibb

6.6.1 Bristol Myers Squibb Corporation Information

6.6.2 Bristol Myers Squibb Description and Business Overview

6.6.3 Bristol Myers Squibb Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Bristol Myers Squibb Oncology Therapeutic Drug Product Portfolio

6.7.5 Bristol Myers Squibb Recent Developments/Updates

6.8 Celgene

6.8.1 Celgene Corporation Information

6.8.2 Celgene Description and Business Overview

6.8.3 Celgene Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)

6.8.4 Celgene Oncology Therapeutic Drug Product Portfolio

6.8.5 Celgene Recent Developments/Updates

6.9 Eisai

6.9.1 Eisai Corporation Information

6.9.2 Eisai Description and Business Overview

6.9.3 Eisai Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)

6.9.4 Eisai Oncology Therapeutic Drug Product Portfolio

6.9.5 Eisai Recent Developments/Updates

6.10 Eli Lilly and Company

6.10.1 Eli Lilly and Company Corporation Information

6.10.2 Eli Lilly and Company Description and Business Overview

6.10.3 Eli Lilly and Company Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)

6.10.4 Eli Lilly and Company Oncology Therapeutic Drug Product Portfolio

6.10.5 Eli Lilly and Company Recent Developments/Updates

6.11 Gilead Sciences

6.11.1 Gilead Sciences Corporation Information

6.11.2 Gilead Sciences Oncology Therapeutic Drug Description and Business Overview

6.11.3 Gilead Sciences Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)

6.11.4 Gilead Sciences Oncology Therapeutic Drug Product Portfolio

6.11.5 Gilead Sciences Recent Developments/Updates

6.12 Ipsen

6.12.1 Ipsen Corporation Information

6.12.2 Ipsen Oncology Therapeutic Drug Description and Business Overview

6.12.3 Ipsen Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)

6.12.4 Ipsen Oncology Therapeutic Drug Product Portfolio

6.12.5 Ipsen Recent Developments/Updates

6.13 Johnson and Johnson

6.13.1 Johnson and Johnson Corporation Information

6.13.2 Johnson and Johnson Oncology Therapeutic Drug Description and Business Overview

6.13.3 Johnson and Johnson Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)

6.13.4 Johnson and Johnson Oncology Therapeutic Drug Product Portfolio

6.13.5 Johnson and Johnson Recent Developments/Updates

6.14 Merck

6.14.1 Merck Corporation Information

6.14.2 Merck Oncology Therapeutic Drug Description and Business Overview

6.14.3 Merck Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)

6.14.4 Merck Oncology Therapeutic Drug Product Portfolio

6.14.5 Merck Recent Developments/Updates

6.15 Novartis

6.15.1 Novartis Corporation Information

6.15.2 Novartis Oncology Therapeutic Drug Description and Business Overview

6.15.3 Novartis Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)

6.15.4 Novartis Oncology Therapeutic Drug Product Portfolio

6.15.5 Novartis Recent Developments/Updates

6.16 Otsuka Pharmaceutical

6.16.1 Otsuka Pharmaceutical Corporation Information

6.16.2 Otsuka Pharmaceutical Oncology Therapeutic Drug Description and Business Overview

6.16.3 Otsuka Pharmaceutical Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)

6.16.4 Otsuka Pharmaceutical Oncology Therapeutic Drug Product Portfolio

6.16.5 Otsuka Pharmaceutical Recent Developments/Updates

6.17 Pfizer

6.17.1 Pfizer Corporation Information

6.17.2 Pfizer Oncology Therapeutic Drug Description and Business Overview

6.17.3 Pfizer Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)

6.17.4 Pfizer Oncology Therapeutic Drug Product Portfolio

6.17.5 Pfizer Recent Developments/Updates

6.18 F. Hoffmann-La Roche

6.18.1 F. Hoffmann-La Roche Corporation Information

6.18.2 F. Hoffmann-La Roche Oncology Therapeutic Drug Description and Business Overview

6.18.3 F. Hoffmann-La Roche Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)

6.18.4 F. Hoffmann-La Roche Oncology Therapeutic Drug Product Portfolio

6.18.5 F. Hoffmann-La Roche Recent Developments/Updates

6.19 Sanofi

6.19.1 Sanofi Corporation Information

6.19.2 Sanofi Oncology Therapeutic Drug Description and Business Overview

6.19.3 Sanofi Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)

6.19.4 Sanofi Oncology Therapeutic Drug Product Portfolio

6.19.5 Sanofi Recent Developments/Updates

6.20 Takeda Pharmaceutical

6.20.1 Takeda Pharmaceutical Corporation Information

6.20.2 Takeda Pharmaceutical Oncology Therapeutic Drug Description and Business Overview

6.20.3 Takeda Pharmaceutical Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)

6.20.4 Takeda Pharmaceutical Oncology Therapeutic Drug Product Portfolio

6.20.5 Takeda Pharmaceutical Recent Developments/Updates

6.21 Teva Pharmaceutical Industries

6.21.1 Teva Pharmaceutical Industries Corporation Information

6.21.2 Teva Pharmaceutical Industries Oncology Therapeutic Drug Description and Business Overview

6.21.3 Teva Pharmaceutical Industries Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)

6.21.4 Teva Pharmaceutical Industries Oncology Therapeutic Drug Product Portfolio

6.21.5 Teva Pharmaceutical Industries Recent Developments/Updates

7 Oncology Therapeutic Drug Manufacturing Cost Analysis

• 7.1 Oncology Therapeutic Drug Key Raw Materials Analysis
• 7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Oncology Therapeutic Drug

7.4 Oncology Therapeutic Drug Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Oncology Therapeutic Drug Distributors List
• 8.3 Oncology Therapeutic Drug Customers

9 Oncology Therapeutic Drug Market Dynamics

• 9.1 Oncology Therapeutic Drug Industry Trends
• 9.2 Oncology Therapeutic Drug Market Drivers
• 9.3 Oncology Therapeutic Drug Market Challenges
• 9.4 Oncology Therapeutic Drug Market Restraints

10 Global Market Forecast

• 10.1 Oncology Therapeutic Drug Market Estimates and Projections by Type
• 10.1.1 Global Forecasted Sales of Oncology Therapeutic Drug by Type (2023-2028)

10.1.2 Global Forecasted Revenue of Oncology Therapeutic Drug by Type (2023-2028)

10.2 Oncology Therapeutic Drug Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Oncology Therapeutic Drug by Application (2023-2028)

10.2.2 Global Forecasted Revenue of Oncology Therapeutic Drug by Application (2023-2028)

10.3 Oncology Therapeutic Drug Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Oncology Therapeutic Drug by Region (2023-2028)

10.3.2 Global Forecasted Revenue of Oncology Therapeutic Drug by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
• 12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

Industry Insights
Due to the COVID-19 pandemic, the global Oncology Therapeutic Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Oncology Therapeutic Drug market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Oncology Therapeutic Drug landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

Chemotherapy accounting for % of the Oncology Therapeutic Drug global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Breast Cancer segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.

The global major manufacturers of Oncology Therapeutic Drug include AbbVie, Amgen, Astellas Pharma, AstraZeneca, Bayer, Biogen, Bristol Myers Squibb, Celgene and Eisai, etc. In terms of revenue, the global 3 largest players have a % market share of Oncology Therapeutic Drug in 2021.

This report focuses on Oncology Therapeutic Drug volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Oncology Therapeutic Drug market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Oncology Therapeutic Drug market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

Chemotherapy

Targeted Therapy

Immunotherapy

Hormonal Therapy

Others

Segment by Application

Breast Cancer

Gastrointestinal Cancer

Prostate Cancer

Respiratory and Lung Cancer

Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

AbbVie

Amgen

Astellas Pharma

AstraZeneca

Bayer

Biogen

Bristol Myers Squibb

Celgene

Eisai

Eli Lilly and Company

Gilead Sciences

Ipsen

Johnson and Johnson

Merck

Novartis

Otsuka Pharmaceutical

Pfizer

F. Hoffmann-La Roche

Sanofi

Takeda Pharmaceutical

Teva Pharmaceutical Industries

Frequently Asked Questions

Which product segment grabbed the largest share in the Oncology Therapeutic Drug market?

How is the competitive scenario of the Oncology Therapeutic Drug market?

Which are the key factors aiding the Oncology Therapeutic Drug market growth?

Which are the prominent players in the Oncology Therapeutic Drug market?

Which region holds the maximum share in the Oncology Therapeutic Drug market?

What will be the CAGR of the Oncology Therapeutic Drug market during the forecast period?

Which application segment emerged as the leading segment in the Oncology Therapeutic Drug market?

What key trends are likely to emerge in the Oncology Therapeutic Drug market in the coming years?

What will be the Oncology Therapeutic Drug market size by 2028?

Which company held the largest share in the Oncology Therapeutic Drug market?